Rainier Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (NCT03123055) | Rainier Therapeutics | 2017-04-20 |
| Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (NCT02401542) | Rainier Therapeutics | 2015-06-01 |
Track Rainier Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.